Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis (Q41718876)

8 October 2017

Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis (English)

1 reference

8 October 2017

0 references

9

1 reference

8 October 2017

Hans-Joachim Mollenkopf

7

object named as

Hans-Joachim Mollenkopf

0 references

Vladimir Yeremeev

object named as

Vladimir Yeremeev

8

0 references

author name string

Julia K Knaul

1

1 reference

8 October 2017

Sabine Jörg

2

1 reference

8 October 2017

Dagmar Oberbeck-Mueller

3

1 reference

8 October 2017

Ellen Heinemann

4

1 reference

8 October 2017

Lisa Scheuermann

5

1 reference

8 October 2017

Volker Brinkmann

6

1 reference

8 October 2017

Anca Dorhoi

10

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 November 2014

1 reference

American Journal of Respiratory and Critical Care Medicine

8 October 2017

1 reference

8 October 2017

190

1 reference

8 October 2017

9

1 reference

8 October 2017

1053-1066

1 reference

The immune response in tuberculosis

8 October 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Neutrophils in tuberculosis: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

History of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Myeloid-derived suppressor cells in parasitic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

The adaptor molecule CARD9 is essential for tuberculosis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Profiling early lung immune responses in the mouse model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Down-regulation of PLCγ2-β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

IDO is a nodal pathogenic driver of lung cancer and metastasis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Transcription factors in myeloid-derived suppressor cell recruitment and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Reciprocal relationship between myeloid-derived suppressor cells and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Gr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Demand-adapted regulation of early hematopoiesis in infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

IL-6 cooperates with G-CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Induction of Bv8 expression by granulocyte colony-stimulating factor in CD11b+Gr1+ cells: key role of Stat3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Cytokine properties of prokineticins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Non-opsonic recognition of Mycobacterium tuberculosis by phagocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

All-trans retinoic acid-triggered antimicrobial activity against Mycobacterium tuberculosis is dependent on NPC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

A role for immature myeloid cells in immune senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201405-0828OC

10.1164/RCCM.201405-0828OC

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference